%0 Journal Article %1 pignatti2015structured %A Pignatti, F. %A Ashby, D. %A Brass, E. P. %A Eichler, H-G %A Frey, P. %A Hillege, H. L. %A Hori, A. %A Levitan, B. %A Liberti, L. %A Löfstedt, R. E. %A McAuslane, N. %A Micaleff, A. %A Noel, R. A. %A Postmus, D. %A Renn, Ortwin %A Sabourin, B. J. %A Salmonson, T. %A Walker, S. %D 2015 %I Wiley-Blackwell %J Clinical pharmacology & therapeutics %K %N 5 %P 522-533 %R 10.1002/cpt.203 %T Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions %V 98

@article{pignatti2015structured, added-at = {2023-08-31T14:54:08.000+0200}, affiliation = {Pignatti, F (Reprint Author), European Med Agcy, London, England. Pignatti, F.; Eichler, H-G; Postmus, D., European Med Agcy, London, England. Ashby, D., Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England. Brass, E. P., Harbor UCLA Med Ctr, Dept Med, Torrance, CA 90509 USA. Frey, P., Food & Drug Adm, Silver Spring, MD USA. Hillege, H. L., Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands. Hori, A., Pharmaceut & Med Devices Agcy, Tokyo, Japan. Levitan, B., Janssen Pharmaceut Res & Dev, Titusville, NJ USA. Liberti, L.; McAuslane, N.; Walker, S., CIRS, London, England. Loefstedt, R. E., Univ Surrey, Risk Res Grp, Ctr Environm Strategy, Guildford GU2 5XH, Surrey, England. Micaleff, A., Merck Serono, Geneva, Switzerland. Noel, R. A., Eli Lilly & Co, Indianapolis, IN 46285 USA. Renn, O., Univ Stuttgart, Inst Sozialwissensch, D-70174 Stuttgart, Germany. Sabourin, B. J., Hlth Canada, Ottawa, ON K1A 0L2, Canada. Salmonson, T., Lakemedelsverket, Uppsala, Sweden.}, author = {Pignatti, F. and Ashby, D. and Brass, E. P. and Eichler, H-G and Frey, P. and Hillege, H. L. and Hori, A. and Levitan, B. and Liberti, L. and Löfstedt, R. E. and McAuslane, N. and Micaleff, A. and Noel, R. A. and Postmus, D. and Renn, Ortwin and Sabourin, B. J. and Salmonson, T. and Walker, S.}, biburl = {https://puma.ub.uni-stuttgart.de/bibtex/20a6799e897e33fbd88feb05391478b24/puma-wartung}, doi = {10.1002/cpt.203}, interhash = {1914d24ef80a098ae09d6422d411b5b4}, intrahash = {0a6799e897e33fbd88feb05391478b24}, issn = {{1532-6535} and {0009-9236}}, journal = {Clinical pharmacology & therapeutics}, keywords = {}, language = {eng}, number = 5, pages = {522-533}, publisher = {Wiley-Blackwell}, research-areas = {Pharmacology & Pharmacy}, timestamp = {2023-08-31T12:54:08.000+0200}, title = {Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions}, unique-id = {ISI:000363405000022}, volume = 98, year = 2015 }